Market revenue in 2023 | USD 135.0 million |
Market revenue in 2030 | USD 245.2 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 66.89% in 2023. Horizon Databook has segmented the North America biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
North America was one of the major contributors to the growth of medical device outsourcing market in 2023. This region is home to numerous medical device companies, which are outsourcing parts of their regulatory and consulting functions to regulatory service providers, thereby contributing to the growth of the medical device outsourcing market.
The high cost of R&D is a major challenge, which has encouraged various medical device companies in North America to outsource functions to third-party vendors with high levels of expertise in the domain. The rapid increase in the manufacturing of medical devices to meet the high demand for efficient healthcare in the region is expected to be one of the major factors contributing to the market growth in North America.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America biological skin substitutes market , including forecasts for subscribers. This continent databook contains high-level insights into North America biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account